A Phase III Trial Evaluating Fruquintinib Efficacy and Safety in 3+ Line Colorectal Cancer Patients （FRESCO)

NCT02314819 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

416

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: fruquintinib
DRUG: placebo

Sponsor

Hutchison Medipharma Limited

Collaborators

[object Object]
[object Object]